Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

UPDATE: Mersana Therapeutics (MRSN) Prices 21.25M Share Common Offering at $4/ShMarch 1, 2019 7:05 AM Mersana Therapeutics (MRSN) is Said to Offer $70M Shares at $4/Share - BloombergFebruary 28, 2019 5:03 PM Mersana Therapeutics Announces Proposed Public Offering of Common StockFebruary 28, 2019 4:04 PM